A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
Clinical trial NCT04955834 · UNKNOWN
Trial details
- NCT number
- NCT04955834
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2025-12-31
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.